Revenue: $71,000 (YoY -18.39%, QoQ -32.38%). Gross Profit: $10,000, Gross Margin ≈ 14.08% (YoY -88.51%, QoQ +100.20%). Operating Income: -$5,534,000, Operating Margin ≈ -77.94% (YoY +22.06%, QoQ -6.16%). Net Income: -$5,293,000, Net Margin ≈ -74.55% (YoY +30.57%, QoQ -7.91%). EPS: -$1.01 (YoY +33.55%, QoQ -5.21%). Liquidity: Cash $7.35m; Short-term investments $18.93m; Total cash and short-term investments ≈ $26.28m; Net debt ≈ $22.73m; Total assets $36.39m; Total liabilities $34.55m; Total stockholders’ equity ≈ -$0.36m. Cash flow: Net cash from operating activities -$4.20m; Net cash used in investing activities -$5.67m; Free cash flow ≈ -$4.29m. Current ratio 6.05; Debt profile: Long-term debt $29.41m; Total debt $30.08m; Net debt $22.73m. Revenue mix remains ultra-light, with R&D and G&A driving most Opex. Four-quarter trend shows 2024 Q3 revenue of $71k vs 2024 Q2 $105k and 2024 Q4 prior year $111k, reflecting a continued revenue cadence, not yet offset by scalable product sales.